Last updated on April 2016

Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

Brief description of study

This study will examine the tolerability and toxicity of topically applied Nepafenac 0.3% vs ketorolac 0.5% among patients undergoing cataract surgery.

Detailed Study Description

This will be a randomized, prospective, controlled, open-label study, comparing the tolerability and toxicity of two commercially available non-steroidal anti-inflammatory eye drops, nepafenac 0.3% and ketorolac 0.5% (generic formulation). The study will involve one eye of each subject. The study will follow good clinical practices (GCP). The primary outcome measure will be tolerability of the study medication as measured by the eye drop comfort survey instrument.

Clinical Study Identifier: NCT02752646

Contact Investigators or Research Sites near you

Start Over

John Hovanesian, MD

Harvard Eye Associates
Laguna Hills, CA United States
  Connect »

Rachel Crabtree

Cincinnati Eye Institute
Edgewood, KY United States
  Connect »